0.1188
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 4,325 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Timber Pharmaceuticals Inc | TMBR | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.1188 | 04:36:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1188 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 18 | 4,325 | - | 0.09 - 1.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:35:17 | formt | 200 | $ 0.1188 | USD |
Period:
Draw Mode:
Timber Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 15.74M | 132.45M | 132.26M | $ 295.74k | $ - | -0.26 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 0.90% |
Timber Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMBR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1354 | 0.187 | 0.1181 | 0.1437771 | 55,639,551 | -0.0166 | -12.26% |
| 1 Month | 0.27 | 0.2825 | 0.09 | 0.1245108 | 27,463,045 | -0.1512 | -56.0% |
| 3 Months | 0.256 | 0.41 | 0.09 | 0.1452434 | 10,965,363 | -0.1372 | -53.59% |
| 6 Months | 0.3388 | 0.4105 | 0.09 | 0.1611573 | 5,625,692 | -0.22 | -64.94% |
| 1 Year | 0.98 | 1.05 | 0.09 | 0.2653959 | 3,748,978 | -0.8612 | -87.88% |
| 3 Years | 4.11 | 4.17 | 0.09 | 1.11 | 3,352,458 | -3.99 | -97.11% |
| 5 Years | 4.11 | 4.17 | 0.09 | 1.11 | 3,352,458 | -3.99 | -97.11% |
Timber Pharmaceuticals Description
| Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist). |